Michael Jameson

11PUBLICATIONS
27CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer diagnosisCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 13, 2026
Exploration of Safety, Pharmacokinetics and Selected Pharmacodynamic Mechanisms of High-Dose Se-Methylselenocysteine, L-Selenomethionine and Selenite in a Phase Ib Trial in Cancer Patients.

|Jun 21, 2023
Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro-Intestinal Trials Group (AGITG) Annual Scientific Meeting 2022.

Ankit Jain, Kirsten L Gormly, Tamara Glyn

|Oct 20, 2022
Development and Validation of a Machine Learning Approach Leveraging Real-World Clinical Narratives as a Predictor of Survival in Advanced Cancer.

Frank Po-Yen Lin, Osama S M Salih, Nina Scott

|Dec 30, 2021
Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial.

Ezra E W Cohen, Lisle Nabell, Deborah J Wong

|Nov 27, 2021
Remote Skin Cancer Diagnosis: Adding Images to Electronic Referrals Is More Efficient Than Wait-Listing for a Nurse-Led Imaging Clinic.

Leah Jones, Michael Jameson, Amanda Oakley

|Oct 26, 2020
Two cycles of adjuvant carboplatin for clinical stage 1 testicular seminoma in New Zealand centres: A retrospective analysis of efficacy and long-term events.

Elias A Chandran, Aaron Chindewere, Richard North

Pageof 2

Frequent Collaborators

1 joint publications

Navin T Wewala

1 joint publications

Richard J Lobb

1 joint publications

Jonathan S Cebon

1 joint publications

Catriona M McNeil